Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ATYR
ATYR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATYR News
aTyr Pharma Q4 Earnings Beat Expectations
5d ago
seekingalpha
aTYR Pharma Reports Reduced Q4 Loss
5d ago
NASDAQ.COM
aTyr Pharma Sets Timeline for FDA Meeting
Feb 03 2026
seekingalpha
aTyr Pharma Schedules FDA Meeting for efzofitimod Review
Feb 03 2026
Newsfilter
aTyr Pharma Faces Shareholder Lawsuit Investigation Over Phase 3 Trial Disclosures
Dec 15 2025
PRnewswire
aTyr Pharma Faces Shareholder Derivative Claims Investigation Over Phase 3 Trial Disclosures
Dec 11 2025
Globenewswire
aTyr Pharma Class Action Notice: Lead Plaintiff Deadline December 8
Dec 09 2025
PRnewswire
aTyr Pharma Shares Plunge 83.2% Following EFZO-FIT Study Results
Dec 08 2025
Globenewswire
aTyr Pharma Faces Class Action After 83% Stock Collapse Following Drug Trial Failure
Dec 08 2025
Globenewswire
Marex, aTyr, and WPP Face Class Action Lawsuits
Dec 08 2025
Globenewswire
aTyr Pharma Shares Plunge 83.2% Following Disappointing FDA Study Results
Dec 08 2025
PRnewswire
aTyr Pharma Shares Plunge 81% Following Failed Drug Trial, Legal Investigation Launched
Dec 08 2025
Newsfilter
aTyr Pharma Shares Plunge 81% After Failed Drug Trial, Investor Claims Under Investigation
Dec 08 2025
PRnewswire
aTyr Pharma Faces Class Action Lawsuit for Misleading Statements
Dec 08 2025
PRnewswire
aTyr Pharma Faces Class Action After 83% Stock Plunge Following Drug Trial Failure
Dec 06 2025
Globenewswire
aTyr Pharma Faces Class Action Lawsuit Over Alleged Misstatements Affecting Share Prices
Dec 06 2025
Globenewswire
Show More News
